Dr. Matthew Wayne Jackson, MD

Dr. Jackson practices at CHRISTUS St. Vincent Regional Medical Center in Santa Fe, New Mexico, part of CHRISTUS Health.

Dr. Jackson's NPI, 1821359795, was assigned on June 6, 2012. Dr. Jackson graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012. Dr. Jackson holds Colorado license DR.0070527.

Dr. Jackson's primary practice is CHRISTUS St. Vincent Regional Medical Center, at 455 St Michael's Drive, Santa Fe, NM 87505 in Santa Fe County. The practice phone is (505) 983-3361.

Dr. Jackson's primary practice is CHRISTUS St. Vincent Regional Medical Center in Santa Fe, New Mexico, part of CHRISTUS Health. Dr. Jackson is also affiliated with UCHealth Poudre Valley Hospital. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. Jackson to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jackson practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Jackson's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Jackson is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Jackson's licenses on file in 4 states: Colorado, Nebraska, New Mexico and Wyoming.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Jackson treats.

CMS data shows 4,507 Medicare services from Dr. Jackson across 17 procedure codes in 2024, for 462 Medicare patients. Medicare paid $332,797 for them. Every service was in an office.

CMS counts 462 Medicare patients who saw Dr. Jackson in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have cancer, and 68% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jackson's median patient age at 75, with 45% women.

In 2024, Dr. Jackson wrote 252 Medicare Part D claims for 113 patients. 96% of them were for generic drugs. CMS names the drug for 168 of them, across 6 drugs with 11 or more claims each, at $2,495 in total drug cost. In 2023, CMS named 94 claims across 3 drugs.

Dr. Jackson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jackson as offering telehealth.

Dmand AI links 15 papers to Dr. Jackson, published from 2014 to 2018. 2015 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Brachytherapy and Propensity Score. Dr. Jackson has published most often in Brachytherapy. Dr. Jackson's most frequent co-authors are Chad George Rusthoven, MD, Arya Amini, MD and Christine Megan Fisher, MD.

CMS Open Payments shows 159 general payments to Dr. Jackson from 33 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $381.

Dr. Jackson graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012.

Dr. Jackson is in network with 10 carriers, including Aetna, Cigna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.